5XGL

Co-crystal structure of Ac-AChBPP in complex with alpha-conotoxin LvIA

5XGL の概要

• エントリーDOI: 10.2210/pdb5xgl/pdb
• 分子名称: Soluble acetylcholine receptor, Alpha-conotoxin LvIA (2 entities in total)
• 機能のキーワード: co-crystal structure, alpha-conotoxin, ac-achbp, metal binding protein-toxin complex, metal binding protein/toxin
• 由来する生物種: Aplysia californica (California sea hare); 詳細
• タンパク質・核酸の鎖数: 10
• 化学式量合計: 136447.27

構造登録者

Wang, X.Q.,Xu, M.Y.,Luo, S.L.,Zhu, X.P. (登録日: 2017-04-14, 公開日: 2018-06-13, 最終更新日: 2024-11-20)

主引用文献

Xu, M.,Zhu, X.,Yu, J.,Yu, J.,Luo, S.,Wang, X.
The crystal structure of Ac-AChBP in complex with alpha-conotoxin LvIA reveals the mechanism of its selectivity towards different nAChR subtypes
Protein Cell, 8:675-685, 2017

PubMed Abstract: The α3* nAChRs, which are considered to be promising drug targets for problems such as pain, addiction, cardiovascular function, cognitive disorders etc., are found throughout the central and peripheral nervous system. The α-conotoxin (α-CTx) LvIA has been identified as the most selective inhibitor of α3β2 nAChRs known to date, and it can distinguish the α3β2 nAChR subtype from the α6/α3β2β3 and α3β4 nAChR subtypes. However, the mechanism of its selectivity towards α3β2, α6/α3β2β3, and α3β4 nAChRs remains elusive. Here we report the co-crystal structure of LvIA in complex with Aplysia californica acetylcholine binding protein (Ac-AChBP) at a resolution of 3.4 Å. Based on the structure of this complex, together with homology modeling based on other nAChR subtypes and binding affinity assays, we conclude that Asp-11 of LvIA plays an important role in the selectivity of LvIA towards α3β2 and α3/α6β2β3 nAChRs by making a salt bridge with Lys-155 of the rat α3 subunit. Asn-9 lies within a hydrophobic pocket that is formed by Met-36, Thr-59, and Phe-119 of the rat β2 subunit in the α3β2 nAChR model, revealing the reason for its more potent selectivity towards the α3β2 nAChR subtype. These results provide molecular insights that can be used to design ligands that selectively target α3β2 nAChRs, with significant implications for the design of new therapeutic α-CTxs.

PubMed: 28585176
DOI: 10.1007/s13238-017-0426-2

実験手法

X-RAY DIFFRACTION (3.439 Å)